Loading…
STAT3-Mediated Promoter-Enhancer Interaction Up-Regulates Inhibitor of DNA Binding 1 ( ID1 ) to Promote Colon Cancer Progression
High expression of inhibitor of DNA binding 1 ( ) correlates with poor prognosis in colorectal cancer (CRC). Aberrant enhancer activation in regulating transcription is limited. Immunohistochemistry (IHC), quantitative RT-PCR (RT-qPCR) and Western blotting (WB) were used to determine the expression...
Saved in:
Published in: | International journal of molecular sciences 2023-06, Vol.24 (12), p.10041 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | High expression of inhibitor of DNA binding 1 (
) correlates with poor prognosis in colorectal cancer (CRC). Aberrant enhancer activation in regulating
transcription is limited.
Immunohistochemistry (IHC), quantitative RT-PCR (RT-qPCR) and Western blotting (WB) were used to determine the expression of
. CRISPR-Cas9 was used to generate
or enhancer E1 knockout cell lines. Dual-luciferase reporter assay, chromosome conformation capture assay and ChIP-qPCR were used to determine the active enhancers of
. Cell Counting Kit 8, colony-forming, transwell assays and tumorigenicity in nude mice were used to investigate the biological functions of
and enhancer E1.
Human CRC tissues and cell lines expressed a higher level of
than normal controls.
promoted CRC cell proliferation and colony formation. Enhancer E1 actively regulated
promoter activity. Signal transducer and activator of transcription 3 (STAT3) bound to
promoter and enhancer E1 to regulate their activity. The inhibitor of STAT3 Stattic attenuated
promoter and enhancer E1 activity and the expression of
. Enhancer E1 knockout down-regulated
expression level and cell proliferation in vitro and in vivo.
Enhancer E1 is positively regulated by STAT3 and contributes to the regulation of
to promote CRC cell progression and might be a potential target for anti-CRC drug studies. |
---|---|
ISSN: | 1422-0067 1661-6596 1422-0067 |
DOI: | 10.3390/ijms241210041 |